- Home
- HIMS
as 07-08-2024 4:00pm EST
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | SAN FRANCISCO |
| Market Cap: | 4.5B | IPO Year: | N/A |
| Target Price: | $16.92 | AVG Volume (30 days): | 10.7M |
| Analyst Decision: | Buy | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.01 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.65 - $25.74 | Next Earning Date: | 08-05-2024 |
| Revenue: | $959,401,000 | Revenue Growth: | 55.65% |
| Revenue Growth (this year): | 42.78% | Revenue Growth (next year): | 24.58% |
Stock Insider Trading Activity of Hims & Hers Health Inc. (HIMS)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Okupe Oluyemi | HIMS | Chief Financial Officer | Jun 25 '24 | Sell | $22.21 | 11,546 | $256,489.77 | 177,449 | SEC Form 4 |
| Boughton Soleil | HIMS | Chief Legal Officer | Jun 25 '24 | Sell | $22.18 | 2,335 | $51,790.30 | 171,479 | SEC Form 4 |
| Chi Michael | HIMS | Chief Commercial Officer | Jun 24 '24 | Sell | $22.07 | 17,303 | $381,877.21 | 185,326 | SEC Form 4 |
| Dudum Andrew | HIMS | Chief Executive Officer | Jun 20 '24 | Sell | $24.31 | 700 | $17,015.25 | 33,502 | SEC Form 4 |
| Dudum Andrew | HIMS | Chief Executive Officer | Jun 20 '24 | Sell | $23.37 | 26,741 | $624,832.88 | 34,202 | SEC Form 4 |
| Dudum Andrew | HIMS | Chief Executive Officer | Jun 20 '24 | Sell | $22.35 | 18,314 | $409,239.15 | 60,943 | SEC Form 4 |
| Chi Michael | HIMS | Chief Commercial Officer | Jun 20 '24 | Sell | $24.50 | 7,500 | $183,750.00 | 185,326 | SEC Form 4 |
| Becklund Irene | HIMS | PAO | Jun 14 '24 | Sell | $24.10 | 472 | $11,375.20 | 16,154 | SEC Form 4 |
| Becklund Irene | HIMS | PAO | Jun 14 '24 | Sell | $23.59 | 13,241 | $312,355.19 | 2,913 | SEC Form 4 |
| Chi Michael | HIMS | Chief Commercial Officer | Jun 14 '24 | Sell | $23.59 | 25,549 | $602,700.91 | 185,326 | SEC Form 4 |
| Boughton Soleil | HIMS | Chief Legal Officer | Jun 11 '24 | Sell | $21.47 | 2,510 | $53,889.70 | 154,345 | SEC Form 4 |
| Chi Michael | HIMS | Chief Commercial Officer | Jun 10 '24 | Sell | $22.05 | 374,669 | $8,262,500.52 | 176,672 | SEC Form 4 |
| Chi Michael | HIMS | Chief Commercial Officer | Jun 10 '24 | Sell | $22.01 | 17,571 | $386,693.78 | 176,672 | SEC Form 4 |
| Okupe Oluyemi | HIMS | Chief Financial Officer | Jun 6 '24 | Sell | $21.42 | 98,635 | $2,113,225.28 | 146,839 | SEC Form 4 |
| Dudum Andrew | HIMS | Chief Executive Officer | Jun 4 '24 | Sell | $19.73 | 119,049 | $2,348,812.96 | 69,839 | SEC Form 4 |
| Dudum Andrew | HIMS | Chief Executive Officer | Jun 4 '24 | Sell | $20.13 | 69,839 | $1,406,026.68 | 0 | SEC Form 4 |
| Dudum Andrew | HIMS | Chief Executive Officer | Jun 4 '24 | Sell | $19.73 | 90,992 | $1,795,235.76 | 1,219,430 | SEC Form 4 |
| Dudum Andrew | HIMS | Chief Executive Officer | Jun 4 '24 | Sell | $20.13 | 53,452 | $1,076,122.39 | 1,165,978 | SEC Form 4 |
| Chi Michael | HIMS | Chief Commercial Officer | May 31 '24 | Sell | $20.20 | 2,300 | $46,452.18 | 176,672 | SEC Form 4 |
| Chi Michael | HIMS | Chief Commercial Officer | May 31 '24 | Sell | $19.34 | 345,423 | $6,681,586.17 | 225,130 | SEC Form 4 |
| Chi Michael | HIMS | Chief Commercial Officer | May 31 '24 | Sell | $20.17 | 48,458 | $977,305.79 | 176,672 | SEC Form 4 |
| Chi Michael | HIMS | Chief Commercial Officer | May 31 '24 | Sell | $21.00 | 101,962 | $2,141,202.00 | 176,672 | SEC Form 4 |
| Chi Michael | HIMS | Chief Commercial Officer | May 31 '24 | Sell | $20.35 | 19,141 | $389,574.86 | 176,672 | SEC Form 4 |
| Chi Michael | HIMS | Chief Commercial Officer | May 31 '24 | Sell | $20.34 | 4,096 | $83,318.37 | 176,672 | SEC Form 4 |
| Boughton Soleil | HIMS | Chief Legal Officer | May 30 '24 | Sell | $21.17 | 15,207 | $321,973.25 | 156,855 | SEC Form 4 |
Latest Hims & Hers Health Inc. News
HIMS Breaking Stock News: Dive into HIMS Ticker-Specific Updates for Smart Investing
The Wall Street Journal
11 days ago
Hims & Hers Down Sharply Again as Scrutiny Over Ozempic Knockoff Business Grows
The Wall Street Journal
12 days ago
Heard on the Street Wednesday Recap: Land of the Rising Sum
The Wall Street Journal
12 days ago
The War Over Cheaper Ozempic Won’t End Well for Some Investors
Simply Wall St.
25 days ago
Explore These 3 US Growth Companies With High Insider Ownership
The Wall Street Journal
a month ago
The Score: Target, Nvidia, Live Nation and More Stocks That Defined the Week
Yahoo Finance Video
2 months ago
Nvidia earnings, housing market outlook, BNPL regulatory pressure: Market Domination
Yahoo Finance Video
2 months ago
Citigroup downgrades Hims & Hers Health to Neutral from Buy
Yahoo Finance Video
2 months ago
Investors await Nvidia earnings, commodities on the rise: Morning Brief
Share on Social Networks:
Disclaimer
The information presented on this page, "HIMS Hims & Hers Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.